Showing 1-10 of about 23743 articles.
Myriad Genetics, Inc.
SALT LAKE CITY, Dec. 14, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that results of a new validation study of...
Seelos Therapeutics, Inc.
NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
Immunicum AB
Press Release 13 December 2019 Immunicum AB (publ) Announces Resignation of Carlos de Sousa as CEO The Board of Directors of Immunicum announced today that, by mutual agreement, Carlos de Sousa...
Immunicum AB
Pressmeddelande 13 december 2019 Carlos de Sousa avgår som vd för Immunicum AB (publ) Styrelsen i Immunicum har kommit överens med Carlos de Sousa om att han lämnar rollen som verkställande...
Toronto Innovation Acceleration Partners
Toronto, ON, Dec. 12, 2019 (GLOBE NEWSWIRE) -- The low survival rates of three of the four most lethal cancers in North America - pancreatic, colorectal and lung - are associated with KRAS...
ProQR Therapeutics N.V.
LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 11, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA...
Madrigal Pharmaceuticals, Inc.
WEST CONSHOHOCKEN, Pa., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal” or the “Company”), a clinical-stage biopharmaceutical company focused on the...
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova” or the “Company”), a Phase 3-stage biopharmaceutical company discovering and developing novel...
Meticulous Market Research Pvt. Ltd.
London, Dec. 10, 2019 (GLOBE NEWSWIRE) -- According to a new market research report “Flow Cytometry Market by Product (Cell Analyzers, Cell Sorter, Software, Reagents), Technology (Cell Based, Bead...
Equillium
LA JOLLA, Calif., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat...
Showing 1-10 of about 23743 articles.
